Results 291 to 300 of about 1,072,475 (388)

Early diuretic response and outcome prediction in ambulatory worsening heart failure: Natriuresis versus diuresis

ESC Heart Failure, EarlyView.
Abstract Aims Early diuresis and natriuresis are commonly used to assess the efficacy of decongestive therapy following an acute heart failure episode. There is limited knowledge regarding which parameter better predicts adverse clinical outcomes, especially in the outpatient setting.
M. Cobo Marcos, R. de la Espriella, I. Zegri‐Reiriz, P. Llacer, J. Rubio Gracia, J. Comín‐Colet, J. L. Morales‐Rull, P. Diez‐Villanueva, J. de Juan Bagudá, S. Jiménez‐Marrero, C. Ortiz Cortés, M. A. Restrepo‐Córdoba, J. M. García‐Pinilla, E. Barrios, S. del Prado Díaz, J. Núñez   +15 more
wiley   +1 more source

Hepatocyte growth factor and B-type natriuretic peptide as independent predictors of mortality in HFpEF patients. [PDF]

Front Cardiovasc Med
Chen HL, Zhu XT, Zhang W, Cheng XB, Hu ZP.   +4 more
europepmc   +1 more source

Isoproterenol Increases the Level of Plasma Immunoreactive Atrial Natriuretic Peptide in the Anesthetized Rabbit

, 1986
A. J. Rankin, Nicole K Wilson, J. R. Ledsome   +2 more
openalex   +1 more source

Signs of congestion, quality of life and short‐term rehospitalization in patients with heart failure

ESC Heart Failure, EarlyView.
Abstract Aims Signs of congestion are a treatment target in patients with heart failure (HF), as they affect patients' well‐being, and congestion scores are associated with the risk of early readmission. However, which individual sign of congestion has the strongest association with quality of life (QoL) and HF rehospitalization remains uncertain ...
Geert H.D. Voordes, Adriaan A. Voors, Hailun Qin, Jozine M. ter Maaten, Kevin Damman   +4 more
wiley   +1 more source

Effect of Vasoactive Substances on Natriuresis Induced by Atrial Natriuretic Peptide in Isolated Perfused Rat Kidneys.

, 1987
Shosaku Narumi, Yoshiaki Fuji, Mamoru Yoshizawa, Toshiyuki Yasui, Takao Saruta   +4 more
openalex   +2 more sources

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events

ESC Heart Failure, EarlyView.
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna, Elia Rigamonti, Raffaele Zannoni, Vittoria Espeli, Giorgio Moschovitis   +4 more
wiley   +1 more source

Studies on circulation in organs. Effect of atrial natriuretic peptide on hemodynamics of several organs.

, 1989
Hideo Nonaka
openalex   +2 more sources

Impact of age, phenotype and cardio‐renal function on plasma C‐type and B‐type natriuretic peptide forms in an adult population

Clinical Endocrinology, 2013
T. Prickett, R. Olney, Vicky A. Cameron, M. J. Ellis, A. Richards, E. Espiner   +5 more
semanticscholar   +1 more source

Plasma metabolomics identifies signatures that distinguish heart failure with reduced and preserved ejection fraction

ESC Heart Failure, EarlyView.
Abstract Aims Two general phenotypes of heart failure (HF) are recognized: HF with reduced ejection fraction (HFrEF) and with preserved EF (HFpEF). To develop phenotype‐specific approaches to treatment, distinguishing biomarkers are needed. The goal of this study was to utilize quantitative metabolomics on a large, diverse population to replicate and ...
Fawaz Naeem, Teresa C. Leone, Christopher Petucci, Clarissa Shoffler, Ravindra C. Kodihalli, Tiffany Hidalgo, Cheryl Tow‐Keogh, Jessica Mancuso, Iphigenia Tzameli, Donald Bennett, John D. Groarke, Rachel J. Roth Flach, Daniel J. Rader, Daniel P. Kelly   +13 more
wiley   +1 more source